Dr. Natalie Clark
@nmclark2.bsky.social
Computational Scientist in the Proteomics Platform at the Broad Institute. Systems biologist integrating ALL the omics data. Views are my own. She/her.
Wasn't all my expertise but leaving plant biology behind after ~10 years was pretty scary. After 3.5 years I still miss the field. But I don't regret my decision.
August 29, 2025 at 11:50 AM
Wasn't all my expertise but leaving plant biology behind after ~10 years was pretty scary. After 3.5 years I still miss the field. But I don't regret my decision.
Wow, congratulations!
August 25, 2025 at 6:52 PM
Wow, congratulations!
It is? Says "including proposals from Pfizer"
August 6, 2025 at 1:20 PM
It is? Says "including proposals from Pfizer"
Check out the Broad Institute's press release for a great summary of key highlights: www.broadinstitute.org/news/study-f...
Study finds biomarkers, drug targets, risk factors for most common form of lung cancer
Large analysis of genes and proteins in lung adenocarcinoma points to possible new diagnostic and treatment approaches, and also reveals signatures of chemical exposures in patients who have never smo...
www.broadinstitute.org
August 1, 2025 at 1:49 PM
Check out the Broad Institute's press release for a great summary of key highlights: www.broadinstitute.org/news/study-f...
We uncover:
🔹 Genomic fragmentation as a prognostic hallmark
🔹 Distinct immune and carcinogen-driven tumor subtypes
🔹 ALK fusion driven phosphosignaling events
🔹 “Late-like” features in early-stage disease
🔹 A subtype-specific therapeutic vulnerability atlas
🔹 Genomic fragmentation as a prognostic hallmark
🔹 Distinct immune and carcinogen-driven tumor subtypes
🔹 ALK fusion driven phosphosignaling events
🔹 “Late-like” features in early-stage disease
🔹 A subtype-specific therapeutic vulnerability atlas
August 1, 2025 at 1:49 PM
We uncover:
🔹 Genomic fragmentation as a prognostic hallmark
🔹 Distinct immune and carcinogen-driven tumor subtypes
🔹 ALK fusion driven phosphosignaling events
🔹 “Late-like” features in early-stage disease
🔹 A subtype-specific therapeutic vulnerability atlas
🔹 Genomic fragmentation as a prognostic hallmark
🔹 Distinct immune and carcinogen-driven tumor subtypes
🔹 ALK fusion driven phosphosignaling events
🔹 “Late-like” features in early-stage disease
🔹 A subtype-specific therapeutic vulnerability atlas
This has been happening in the greater Boston area for weeks now. Absolutely sickening.
June 14, 2025 at 1:36 AM
This has been happening in the greater Boston area for weeks now. Absolutely sickening.
There is a well documented shortage of PCPs nationwide.
www.nbcboston.com/news/local/w... (specific to Boston, but the points are true nationwide)
www.nbcboston.com/news/local/w... (specific to Boston, but the points are true nationwide)
What can be done about the primary care doctor shortage in Mass.?
Health care providers across Massachusetts are grappling with a shortage of primary care physicians. A recent report published by the Massachusetts Health Policy Commission (HPC) found that wait times...
www.nbcboston.com
May 9, 2025 at 7:59 PM
There is a well documented shortage of PCPs nationwide.
www.nbcboston.com/news/local/w... (specific to Boston, but the points are true nationwide)
www.nbcboston.com/news/local/w... (specific to Boston, but the points are true nationwide)
Definitely don't ask Gemini to try spelling it for you...
April 30, 2025 at 2:25 PM
Definitely don't ask Gemini to try spelling it for you...
83 here in Boston... Too hot!!!
April 19, 2025 at 5:51 PM
83 here in Boston... Too hot!!!
Only applies to R 4.0-4.3 AFAIK (unless this is a newer vulnerability?) Upgrading to 4.4+ seems the easiest fix.
April 4, 2025 at 7:48 PM
Only applies to R 4.0-4.3 AFAIK (unless this is a newer vulnerability?) Upgrading to 4.4+ seems the easiest fix.
There are many things I miss about NC but this is not one of them. Looking at the image made my eyes itchy.
March 27, 2025 at 10:38 AM
There are many things I miss about NC but this is not one of them. Looking at the image made my eyes itchy.